Application no. and date | 01909086.9 (espacenet) (Federated) (European Patent Register), 20010208 | Patent/reg. no. and date | DK/EP 1299104, 20090513 | Publication date | 20030409 | Priority no. and date | US 181369 P, 20000208 | EP pub. no. and date |
EP 1299104 20030409 | Effective date | | Applicant/owner | EURO-CELTIQUE S.A., 1, rue Jean Piret 2350 Luxembourg , LU | Applicant ref. no. | P80902561DK00E | Inventor | OSHLACK, Benjamin, 351 East 84th Street
New York, NY 10028, US, WRIGHT, Curtis, 1 Jarvis Street
Norwalk, CT 06851, US, HADDOX, J., David, 23 Chadwick Court
Upper Stepney, CT 06468, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/485 (2006.01) , A61K 9/16 (2006.01) , A61K 9/20 (2006.01) , A61K 9/28 (2006.01) , A61K 9/50 (2006.01) , A61P 25/04 (2006.01) , A61P 25/36 (2006.01) | Title | Orale opioidagonistformuleringer sikret mod forfalskning | Int. application no. | US2001004346 | Int. publication no. | WO2001058451 | Related patent (certificate) | | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|